Company intelligence / Profile preview

Regenerative Medical Technology Group

Boca Raton, Florida, United States

Ownership: Private
Development stage: Other

Overview

Regenerative Medical Technology Group offers commercialization of stem cell and exosome-based therapies across a global clinical and training network, with direct-to-patient services and clinical supply operations. Financial results show positive operating profit and rapid sales growth, but there are no explicit reports of pivotal clinical trial outcomes or regulatory drug approvals.

Therapeutic areas: ImmunologyOtherDermatologyRheumatology
Modalities: Cell therapyStem cell therapyExosome-based therapyNK cell therapy
Industry: Biotech

Partnerships

ISSCA (International Society for Stem Cell Application)Dr. Juan C. Ramos and Dr. Aleida G. Nieves (strategic partners in Puerto Rico)Hyatt Hotel Dubai (clinic site)

Beyond the preview

Go deeper on Regenerative Medical Technology Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenerative Medical Technology Group.

Explore the full profile